# AveXis, Inc.: Form D filing

AveXis, Inc., a biotechnology company in Bannockburn, IL, filed a Form D with the SEC in 2015. The latest, on September 17, 2015, reports $65 million sold of a $65 million offering to 27 investors.

Find out what AveXis, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20AveXis%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=AveXis%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Favexis-inc-1652923)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20AveXis%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=AveXis%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Favexis-inc-1652923)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Illinois](https://specstream.ai/data/form-d/state/illinois): 1,511 rows, by operating companies, filed since November 1, 2024, $75.55, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/illinois
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 2275 HALF DAY ROAD, SUITE 160, Bannockburn, IL, 60015
- Phone: (972) 725-7797
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2012
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1652923

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Sep 17, 2015 | New notice | $65,000,020 | $65,000,020 | $0 | 27 | Sep 3, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1652923/000123191915000025/0001231919-15-000025-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| James F. L'Italien | Executive Officer |  |
| Andrew F. Knudten | Executive Officer |  |
| Paul D. Manning | Director |  |
| Sukumar F. Nagendran | Executive Officer |  |
| Bong D. Koh | Director |  |
| Thomas D. Dee | Executive Officer |  |
| Sean Nolan | Executive Officer, Director |  |
| Carole D. Nuechterlain | Director |  |
| Brian D. Kaspar | Executive Officer, Director |  |
| Jonathan D. Leff | Director |  |
| John D. Harkey | Director |  |

## Other biotechnology companies in Illinois that filed recently

- [Neopenda, PBC](https://specstream.ai/data/form-d/company/neopenda-pbc-1751635) $215,000 · Aug 27, 2026
- [Auvi Labs, Inc.](https://specstream.ai/data/form-d/company/auvi-labs-inc-2097988) $442,352 · Aug 26, 2026
- [Archean Sciences, Inc.](https://specstream.ai/data/form-d/company/archean-sciences-inc-2150107) $385,000 · Aug 13, 2026

[Every Form D from the week of Sep 14, 2015](https://specstream.ai/data/form-d/week/2015-09-14) · [All recent filings in Illinois](https://specstream.ai/data/form-d/state/illinois) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what AveXis, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).